23 Conclusion Allulose represents a novel therapeutic approach combining the taste of conventional sugars with GLP-1-like metabolic benefits
In 2024, compounding facilities in Kansas, Pennsylvania, New Jersey and California received FDA warning letters after inspectors identified problems with sterility in their facilities
10.4137/BCBCR.S7156 65 PalH
Microbiota changes in PD The fact that PD patients exhibit changes in the gut microbiota composition and intestinal inflammation has been presented multiple times [109, 127,128,129,130]
This formulation utilizes Intravail technology utilizing n-dodecyl--D-maltoside (DDM) to temporarily loosen intercellular mucosal junctions, facilitating rapid systemic absorption of epinephrine even through congested nasal passages (Howell, 2024